Darzalex (daratumumab) 400 mg/20 mL, 1 vial, Janssen Darzalex (daratumumab) is used for multiple myeloma. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
Indications
Darzalex®recognize:
- in combination with bortezomib, melphalan, and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are not candidates for autologous stem cell transplantation;
- as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who had disease progression during the last therapy;
- as part of combination therapy with lenalidomide and dexamethasone or bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one line of therapy.
- Trade name:Darzalex
- Chemical name:Daratumumab
- Dosage:400 mg
- Quantity:1
- Dosage form:Vial
No reviews yet
